Your browser doesn't support javascript.
loading
Type 1 interferon suppresses expression and glucocorticoid induction of glucocorticoid-induced leucine zipper (GILZ).
Dankers, Wendy; Northcott, Melissa; Bennett, Taylah; D'Cruz, Akshay; Sherlock, Rochelle; Gearing, Linden J; Hertzog, Paul; Russ, Brendan; Miceli, Iolanda; Scheer, Sebastian; Fujishiro, Maki; Hayakawa, Kunihiro; Ikeda, Keigo; Morand, Eric F; Jones, Sarah A.
Afiliação
  • Dankers W; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia.
  • Northcott M; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia.
  • Bennett T; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia.
  • D'Cruz A; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia.
  • Sherlock R; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia.
  • Gearing LJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
  • Hertzog P; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
  • Russ B; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia.
  • Miceli I; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia.
  • Scheer S; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia.
  • Fujishiro M; Institutes for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan.
  • Hayakawa K; Institutes for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan.
  • Ikeda K; Institutes for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan.
  • Morand EF; Department of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Chiba, Japan.
  • Jones SA; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia.
Front Immunol ; 13: 1034880, 2022.
Article em En | MEDLINE | ID: mdl-36505447
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Inibidores de Janus Quinases Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Inibidores de Janus Quinases Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália País de publicação: Suíça